We are live on ! Find out more
AC

AltraVue Capital Portfolio holdings

AUM $1.16B
1-Year Est. Return 46.45%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+46.45%
3 Year Est. Return
+174.8%
5 Year Est. Return
+275.79%
10 Year Est. Return
AUM
$564M
AUM Growth
+$112M
Cap. Flow
+$76.5M
Cap. Flow %
13.56%
Top 10 Hldgs %
52.53%
Holding
35
New
2
Increased
27
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
SNEX icon
StoneX
SNEX
+$21.9M
2
BGC icon
BGC Group
BGC
+$13.2M
3
BBCP icon
Concrete Pumping Holdings
BBCP
+$8.25M
4
CCF
Chase Corporation
CCF
+$4.41M
5
QADA
QAD Inc.
QADA
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Healthcare 18.41%
3 Industrials 14.83%
4 Financials 13.94%
5 Real Estate 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDMO
1
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$56.1M 9.94%
2,186,956
-153,244
-7% -$3.27M
QADA
2
DELISTED
QAD Inc.
QADA
$42.2M 7.48%
484,892
+56,883
+13% +$4.15M
SNEX icon
3
StoneX
SNEX
$7.81B
$34.5M 6.11%
2,876,821
+1,694,479
+143% +$21.9M
NOMD icon
4
Nomad Foods
NOMD
$1.63B
$32.7M 5.8%
1,157,753
+139,090
+14% +$4.09M
AGYS icon
5
Agilysys
AGYS
$3.02B
$24.4M 4.32%
428,287
+42,450
+11% +$2.2M
IESC icon
6
IES Holdings
IESC
$15B
$23.6M 4.19%
459,871
+41,124
+10% +$2.13M
FSV icon
7
FirstService
FSV
$6.27B
$21.9M 3.89%
128,025
+16,950
+15% +$2.78M
UFPT icon
8
UFP Technologies
UFPT
$2.51B
$21.4M 3.79%
372,411
+37,421
+11% +$2.03M
PLUS icon
9
ePlus
PLUS
$2.35B
$20.3M 3.6%
469,180
+56,566
+14% +$2.7M
SHO icon
10
Sunstone Hotel Investors
SHO
$2.01B
$19.3M 3.41%
1,550,677
+205,650
+15% +$2.62M
MLI icon
11
Mueller Industries
MLI
$15.2B
$18.2M 3.23%
1,683,712
+219,652
+15% +$2.48M
CCF
12
DELISTED
Chase Corporation
CCF
$17M 3.02%
166,093
+39,822
+32% +$4.41M
AGX icon
13
Argan
AGX
$8.15B
$16M 2.84%
335,726
+42,103
+14% +$2.1M
NRIM icon
14
Northrim BanCorp
NRIM
$588M
$15.4M 2.73%
1,442,036
+135,208
+10% +$1.47M
PLTR icon
15
Palantir
PLTR
$421B
$15.3M 2.71%
580,400
ALEX
16
DELISTED
Alexander & Baldwin
ALEX
$14.6M 2.59%
799,065
+184,130
+30% +$3.39M
BKR icon
17
Baker Hughes
BKR
$63.6B
$14.4M 2.55%
628,340
+61,400
+11% +$1.42M
PARR icon
18
Par Pacific Holdings
PARR
$3.59B
$14.3M 2.54%
852,732
+83,789
+11% +$1.26M
HCKT icon
19
Hackett Group
HCKT
$279M
$14.1M 2.5%
784,128
+76,449
+11% +$1.33M
UNH icon
20
UnitedHealth
UNH
$371B
$13.9M 2.46%
34,690
+8,360
+32% +$3.33M
SAFT icon
21
Safety Insurance
SAFT
$1.52B
$13.4M 2.38%
171,712
+43,004
+33% +$3.59M
MAR icon
22
Marriott International
MAR
$90.9B
$13.3M 2.35%
97,300
+20,730
+27% +$2.99M
BGC icon
23
BGC Group
BGC
$4.86B
$13M 2.31%
+2,300,820
New +$13.2M
DG icon
24
Dollar General
DG
$27B
$12.6M 2.23%
58,120
+13,780
+31% +$2.9M
CABO icon
25
Cable One
CABO
$203M
$12.5M 2.22%
6,550
+1,760
+37% +$3.17M

Similar funds

AltraVue Capital's Q2 2021 Portfolio in Review

As of Q2 2021, AltraVue Capital held 35 positions worth $564M, up 25% from $452M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

AltraVue Capital deployed $76.5M of net new capital in Q2 2021, opening 2 new positions and adding to 27 existing holdings. Its largest new stake was BGC Group: 2,300,820 shares worth $13M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Avid Bioservices, Inc. Common Stock, an estimated $3.27M trimmed.

  • AltraVue Capital's largest Q2 2021 buy was BGC Group: 2,300,820 shares worth $13M.
  • AltraVue Capital added most to StoneX in Q2 2021, an estimated $21.9M increase.
  • AltraVue Capital's biggest Q2 2021 reduction was Avid Bioservices, Inc. Common Stock, cutting an estimated $3.27M.
  • AltraVue Capital fully exited Bryn Mawr Bank Corp in Q2 2021, selling an estimated $18.2M.
  • AltraVue Capital's ten largest holdings make up 53% of its $564M portfolio in Q2 2021.
  • AltraVue Capital opened 2 new positions and closed 2 in Q2 2021.
  • AltraVue Capital's portfolio value rose 25% quarter-over-quarter to $564M.

Based on AltraVue Capital's 13F filing for Q2 2021, filed 30 Jul 2021.